An observational study in Peripheral ICC and PICC, sponsored by Access Vascular Inc. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2021-05-26.
Sponsored by Access Vascular Inc · Observational
This is a retrospective, matched pair comparative post market review of 4Fr Single Lumen PICC lines. The subjects will be matched by the timeframe of when the HydroPICCs were inserted.
Subjects would have received a 4 Fr Single Lumen PICC line between Aug 2020 and Oct 2020.
The two groups will be HydroPICCs and the standard of care for the facility.
A comparison of multiple endpoints will be evaluated between the two groups.
Access Vascular Inc is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Any patients at the study site that received a 4 Fr single lumen PICC line from Aug 2020 through Oct 2020.
Exclusion Criteria:
Cohort who received the HydroPICC
Device: HydroPICC
Cohort who received something different than HydroPICC
PICC lines
Also known as: Standard of Care
Intended dwell time based on a comparison of the actual dwell time to the intended time
Comparison of actual vs intended dwell times of each arm
Time frame: August 2020 through October 2020
Comparison of failure rates
Compare the failure rates between the two arms
Time frame: August 2020 through October 2020
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Access Vascular Inc